Home › Funds › SHAPIRO CAPITAL MANAGEMENT LLC › ZBH

SHAPIRO CAPITAL MANAGEMENT LLC position in ZBH

ZIMMER BIOMET HOLDINGS INC · Health Care

SHAPIRO CAPITAL MANAGEMENT LLC reported holding 187,521 shares of ZBH (ZIMMER BIOMET HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$16.7M, representing 1.14% of its reported portfolio and ranking #33 among its reported holdings. SHAPIRO CAPITAL MANAGEMENT LLC has disclosed ZBH holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)187.52K sh
Reported value held$16.66M
Portfolio Weight1.14%
First reportedQ4 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SHAPIRO CAPITAL MANAGEMENT LLC's ZBH position evolved

SHAPIRO CAPITAL MANAGEMENT LLC first disclosed a stake in ZBH in Q4 2023 at 992,540 shares (US$120.8M). The position peaked in Q1 2024 at 921,506 shares, worth US$121.6M. Across 12 filings, SHAPIRO CAPITAL MANAGEMENT LLC increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 187,521 shares valued at US$16.7M — a reduction of -417,890 shares quarter over quarter.. Notable position changes include a 27% trim in Q4 2025 (shares were roughly flat over the following quarter), a 69% trim in Q3 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 992.54K $120.79M New
Q1 2024 921.51K $121.62M Reduce
Q2 2024 1.03M $111.61M Add
Q3 2024 1.00M $107.98M Reduce
Q4 2024 945.13K $99.83M Reduce
Q1 2025 857.76K $97.08M Reduce
Q2 2025 749.89K $68.40M Reduce
Q3 2025 765.49K $75.40M Add
Q4 2025 561.63K $50.50M Reduce
Q1 2026 651.96K $58.95M Add
Q2 2026 605.41K $52.12M Reduce
Q3 2026 187.52K $16.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZBH and 13F data

ZBH (ZIMMER BIOMET HOLDINGS INC) is a Health Care company. 18 other funds we track also report a position in ZBH — the largest reported positions include Dodge & Cox (US$2.08B), DODGE & COX (US$2.08B), Harris Associates (Oakmark) (US$1.10B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZBH

All ZBH fund holders →

FAQ

How long has SHAPIRO CAPITAL MANAGEMENT LLC held ZBH?

SHAPIRO CAPITAL MANAGEMENT LLC has disclosed ZBH holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is SHAPIRO CAPITAL MANAGEMENT LLC's current position in ZBH?

As of Q3 2026, SHAPIRO CAPITAL MANAGEMENT LLC holds 187.52K shares of ZBH (ZIMMER BIOMET HOLDINGS INC), valued at $16.66M, representing 1.14% of its reported portfolio and ranking #33.

Has SHAPIRO CAPITAL MANAGEMENT LLC been buying or selling ZBH?

In the latest 13F filing (Q3 2026), SHAPIRO CAPITAL MANAGEMENT LLC reduced its position in ZBH. The position peaked in Q1 2024 at 921.51K shares.

Which other funds hold ZBH?

Other major institutional holders of ZBH include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.